Talking Precision Medicine – Details, episodes & analysis

What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game. 

Episode 38 links:

• ⁠⁠⁠⁠TPM E38⁠⁠⁠ for highlights and links from this episode >⁠⁠
• ⁠⁠Genialis’ Upcoming Events⁠⁠
• ⁠⁠Genialis™ krasID

In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.

Episode 37 links:

• ⁠⁠⁠⁠TPM E37⁠⁠⁠ for highlights and links from this episode >⁠
• ⁠Genialis’ Upcoming Events⁠
• ⁠Genialis™ krasID

In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.

Visit TPM E28 for highlights and links from this episode.

This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care.

Visit TPM E27 for highlights and links from this episode.

In this episode 26, our host Rafael sits down with Harry Glorikian. Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You, and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it.

Visit TPM E26 for highlights and links from this episode.

Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta, co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it.

Visit TPM 25 for highlights and links from this episode.

Our guest is Dr. Angeli Moeller, Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care.

Visit TPM E24 for highlights and links from this episode.

Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning.

Visit TPM E23 for highlights and links from this episode.

Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe. 

Visit TPM E22 for highlights and links from this episode.

Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.

Visit TPM E21 for highlights and links from this episode.